271 related articles for article (PubMed ID: 23515050)
1. Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease.
Thomas SS; Dong Y; Zhang L; Mitch WE
Kidney Int; 2013 Aug; 84(2):308-16. PubMed ID: 23515050
[TBL] [Abstract][Full Text] [Related]
2. TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease.
Gu L; Wang Z; Zhang Y; Zhu N; Li J; Yang M; Wang L; Rong S
Cell Prolif; 2022 Mar; 55(3):e13181. PubMed ID: 35088922
[TBL] [Abstract][Full Text] [Related]
3. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.
Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
Austin RL; Rune A; Bouzakri K; Zierath JR; Krook A
Diabetes; 2008 Aug; 57(8):2066-73. PubMed ID: 18443205
[TBL] [Abstract][Full Text] [Related]
6. Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells.
Zhang J; Wu W; Li D; Guo Y; Ding H
Endocrine; 2010 Feb; 37(1):157-66. PubMed ID: 20963565
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid alleviates skeletal muscle atrophy in 5/6 nephrectomy rats through the TLR4/MYD88/NF-kB pathway.
He J; He Z; Wang H; Zhang C; Pei T; Yan S; Yan Y; Wang F; Chen Y; Yuan N; Wang M; Xiao W
Biomed Pharmacother; 2024 May; 174():116556. PubMed ID: 38636398
[TBL] [Abstract][Full Text] [Related]
8. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.
Yu R; Chen JA; Xu J; Cao J; Wang Y; Thomas SS; Hu Z
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):327-341. PubMed ID: 27897418
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Berberine on the Insulin Resistance and TLR4/IKKbeta/NF-kappaB Signaling Pathways in Skeletal Muscle of Obese Rats with Insulin Resistance].
Zhang DS; Bai XH; Yao YJ; Mu DZ; Chen J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):827-31. PubMed ID: 26867315
[TBL] [Abstract][Full Text] [Related]
10. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease induces autophagy leading to dysfunction of mitochondria in skeletal muscle.
Su Z; Klein JD; Du J; Franch HA; Zhang L; Hassounah F; Hudson MB; Wang XH
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1128-F1140. PubMed ID: 28381463
[TBL] [Abstract][Full Text] [Related]
12. Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40.
Zhang L; Chen Z; Wang Y; Tweardy DJ; Mitch WE
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E625-E635. PubMed ID: 32101031
[TBL] [Abstract][Full Text] [Related]
13. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway.
Koren-Gluzer M; Aviram M; Hayek T
Atherosclerosis; 2013 Jul; 229(1):71-8. PubMed ID: 23639858
[TBL] [Abstract][Full Text] [Related]
15. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.
Bailey JL; Zheng B; Hu Z; Price SR; Mitch WE
J Am Soc Nephrol; 2006 May; 17(5):1388-94. PubMed ID: 16611720
[TBL] [Abstract][Full Text] [Related]
17. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.
Zhang L; Wang XH; Wang H; Du J; Mitch WE
J Am Soc Nephrol; 2010 Mar; 21(3):419-27. PubMed ID: 20056750
[TBL] [Abstract][Full Text] [Related]
18. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
19. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
20. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.
Zhang L; Du J; Hu Z; Han G; Delafontaine P; Garcia G; Mitch WE
J Am Soc Nephrol; 2009 Mar; 20(3):604-12. PubMed ID: 19158350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
